AROG PHARMACEUTICALS INC has a total of 56 patent applications. It decreased the IP activity by 92.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, China and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and foods and drinks are TEZAPSIDIS NIKOLAOS, UBIVAC LLC and DEL MAR PHARMACEUTICALS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | China | 6 | |
#3 | Australia | 4 | |
#4 | Singapore | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Brazil | 2 | |
#7 | Canada | 2 | |
#8 | Chile | 2 | |
#9 | EPO (European Patent Office) | 2 | |
#10 | Israel | 2 | |
#11 | Republic of Korea | 2 | |
#12 | Mexico | 2 | |
#13 | Peru | 2 | |
#14 | Philippines | 2 | |
#15 | Colombia | 1 | |
#16 | EAPO (Eurasian Patent Organization) | 1 | |
#17 | Hong Kong | 1 | |
#18 | Hungary | 1 | |
#19 | New Zealand | 1 | |
#20 | Serbia | 1 | |
#21 | Taiwan | 1 | |
#22 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Foods and drinks | |
#4 | Biotechnology | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Enzymes | |
#5 | Measuring microorganism processes | |
#6 | Electrotherapy | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Jain Vinay K | 47 |
#2 | Jain Vinay | 6 |
#3 | Vinay K Jain | 2 |
#4 | Jain Vinay K K | 1 |
Publication | Filing date | Title |
---|---|---|
US2021100789A1 | Method of inhibiting mutant c-kit | |
US2021052571A1 | Novel uses of crenolanib | |
CN110840893A | Pharmaceutical composition containing clainib and application thereof | |
US2019183880A1 | Method of inhibiting mutant C-KIT | |
KR20200079351A | Crenolanib for treating flt3 mutated proliferative disorders associated mutations | |
CN112138010A | Application of Crenolanib and pharmaceutically acceptable salt thereof | |
TW201412314A | Method of inhibiting constitutively active phosphorylated flt3 kinase |